Document is current

Any future updates will be listed below

Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells

Crossref DOI link: https://doi.org/10.1186/s12885-016-2730-2

Published Online: 2016-08-31

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark